AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Rebizot D 30mg/20mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Azott Pharmaceuticals Pvt.ltd.

Salt Composition

Domperidone (30mg) + Rabeprazole (20mg)

Overview Rebizot D 30mg/20mg Capsule SR

Gastroesophageal reflux disease (GERD), or acid reflux, can be managed with the dual-action capsule, Rebizot D 30mg/20mg SR. This medication targets acidity symptoms like heartburn and stomach upset by neutralizing stomach acid and facilitating gas expulsion. Dosage and duration are determined by your physician and should be adhered to; premature cessation may exacerbate your condition. The prescribed amount depends on your response to treatment. Always disclose all other medications to your doctor, as interactions are possible. Common side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue, most of which are temporary. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or mentally demanding tasks until the effects are known. Alcohol should be avoided due to potential increased sleepiness. Lifestyle adjustments, such as consuming cold milk and avoiding caffeine, spicy foods, and chocolate, may enhance treatment outcomes. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, and if you are pregnant, planning pregnancy, or breastfeeding.

Primary Ingredients of Rebizot D 30mg/20mg Capsule SR

The information is unavailable.

Uses of Rebizot D 30mg/20mg Capsule SR

Managing gastroesophageal reflux and peptic ulcers.

Major Benefits of Rebizot D 30mg/20mg Capsule SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or breaking it. Rebizot D 30mg/20mg sustained-release capsules should be taken on an empty stomach.

Common Side effects of Rebizot D 30mg/20mg Capsule SR:

  • Cough
  • Headache
  • Diarrhea
  • Dizziness
  • Inflammation of the nose
  • Abdominal pain
  • Vomiting
  • Weakness
  • Nasal congestion (stuffy nose)
  • Insomnia (difficulty in sleeping)
  • Fundic gland polyps
  • Nausea
  • Constipation
  • Flatulence
  • Back pain
  • Pharyngitis

How to use Rebizot D 30mg/20mg Capsule SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire capsule without chewing, crushing, or breaking it. Rebizot D 30mg/20mg Sustained-Release Capsules should be taken on an empty stomach.

How Rebizot D 30mg/20mg Capsule SR works:

Rebizot D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole, working synergistically to manage digestive discomfort. Domperidone, a gastrointestinal motility stimulant, enhances stomach and intestinal contractions, facilitating efficient food transit. Rabeprazole, a proton pump inhibitor (PPI), decreases gastric acid production, thereby alleviating acid reflux and heartburn symptoms.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Rebizot D 30mg/20mg SR capsules with alcohol. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Rebizot D 30mg/20mg sustained-release capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Rebizot D 30mg/20mg capsule is likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Driving may be impaired by Rebizot D 30mg/20mg SR Capsules, which can cause drowsiness, dizziness, and blurred vision. Avoid operating a vehicle if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should use Rebizot D 30mg/20mg sustained-release capsules cautiously. Dosage modification of Rebizot D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Exercise caution when prescribing Rebizot D 30mg/20mg SR capsules to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. Rebizot D 30mg/20mg SR capsules are contraindicated in patients exhibiting moderate to severe liver dysfunction.

What if you forget to take Rebizot D 30mg/20mg Capsule SR :

Should you forget a Rebizot D 30mg/20mg SR Capsule dose, take it immediately if remembered. However, near the time for your next dose, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Rebizot D 30mg/20mg Capsule SR

LabelValue
Potential for Dependence None.
Treatment Category Gastrointestinal system

FAQs on Rebizot D 30mg/20mg Capsule SR

Rebizot D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This dual-action formulation addresses acidity, heartburn, and gastroesophageal reflux disease (GERD), a condition characterized by stomach acid reflux into the esophagus. It's also indicated for gastric and duodenal ulcers. The domperidone component aids in nausea control by stimulating gut motility, facilitating smoother food passage through the stomach.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any other excipient in Rebizot D 30mg/20mg SR Capsules should avoid its use. Renal or hepatic impairment necessitates careful monitoring when administering this medication.
Indeed, taking Rebizot D 30mg/20mg sustained-release capsules may result in xerostomia (dry mouth), a side effect attributed to the domperidone component. Should dry mouth occur, increased water consumption is recommended. Keeping water readily available overnight is advisable. Reducing alcohol intake and abstaining from smoking are also suggested. For dry mouth, consider alcohol-free mouthwash to minimize the potential for dental caries.
Diarrhea is a potential side effect of Rebizot D 30mg/20mg SR capsules. If diarrhea occurs, increased fluid intake is recommended. Fatty or greasy foods should be avoided while taking this medication. Consult your physician if diarrhea continues or if dehydration symptoms, such as reduced urination and dark, strong-smelling urine, appear.
Retain this medication within its original, securely sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent accidental ingestion by children, pets, and others.
Rebizot D 30mg/20mg sustained-release capsules are generally well-tolerated. Nevertheless, some individuals might experience typical side effects such as abdominal discomfort, flatulence, dry mouth, lightheadedness, cephalalgia, or diarrhea. Less frequent or infrequent adverse reactions are also possible. Report any ongoing issues to your physician during treatment.
Optimal administration of Rebizot D 30mg/20mg sustained-release capsules is before the initial meal or while fasting.
Taking Rebizot D 30mg/20mg Sustained-Release Capsules may elevate the likelihood of experiencing an abnormal heart rhythm (a serious arrhythmia). While this is a significant potential adverse effect, the probability of occurrence remains quite small. However, individuals over 60 years old might face a marginally increased risk.
Rebizot D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This dual-action formulation addresses heartburn, acid reflux (GERD—gastroesophageal reflux disease), and ulcers affecting the stomach and duodenum. Rabeprazole manages acidity, while domperidone facilitates improved gut motility, thereby reducing vomiting and easing food passage through the stomach.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any inactive components of Rebizot D 30mg/20mg SR Capsules should avoid its use. Individuals with pre-existing kidney or liver impairment require careful monitoring when considering this medication.
Indeed, taking Rebizot D 30mg/20mg SR capsules may lead to xerostomia (dry mouth). This side effect is attributed to the domperidone component. To alleviate dry mouth, increase your water consumption. Keep a glass of water by your bed at night. Reduce alcohol intake and refrain from smoking. For dry mouth, opt for alcohol-free mouthwash to minimize the potential for dental caries.
Diarrhea is a potential side effect of Rebizot D 30mg/20mg SR Capsules. If diarrhea occurs, increase fluid intake. Restrict consumption of high-fat foods. Consult your physician if diarrhea continues or if dehydration symptoms, such as reduced urination and dark, strong-smelling urine, appear.
Rebizot D 30mg/20mg sustained-release capsules are generally well-tolerated. Nevertheless, some individuals may experience typical side effects including diarrhea, abdominal pain, gas, dry mouth, vertigo, and headache. Less frequent or infrequent adverse reactions are also possible. Report any ongoing issues to your physician during treatment.
Optimal administration of Rebizot D 30mg/20mg sustained-release capsules is before breakfast or on an empty stomach.
Taking Rebizot D 30mg/20mg sustained-release capsules may elevate the likelihood of an irregular heartbeat, a potentially severe arrhythmia. While this is a serious adverse effect, the probability of occurrence remains quite small. However, the risk might be marginally greater for individuals over 60.
Store this medication in its original, tightly sealed container or packaging, following the storage instructions provided on the label or packaging. Discard any unused medication. Prevent access by children, pets, and others.
Rebizot D 30mg/20mg Capsu...
78
MRP 95
17% off